June 30, 2024

PiVOT Makes a Splash at DIA 2024: Showcasing the Philippines’ Clinical Trial Powerhouse Potential

Share on Facebook Share on Twitter Share on Mail

The Drug Information Association’s (DIA) 2024 Global Annual Meeting in San Diego, California, proved to be a resounding success for the leading and largest Philippine CRO (Contract Research Organization), PiVOT. From forging new connections to showcasing the Philippines’ capabilities in clinical research, PiVOT’s participation left a lasting impression.

Highlighting Filipino Excellence: A Successful Showcase

PiVOT’s team successfully exhibited at the event, attracting over 300 potential partners and clients. The booth buzzed with excitement as attendees learned about the Philippines’ growing role in the life sciences sector. Many expressed surprise and delight at the prospect of conducting clinical trials in the Philippines.

This positive reception was further amplified by the warm Filipino hospitality PiVOT offered. Visitors were treated to delightful Philippine snacks, traditional fans, and Yakan coin purses, fostering a sense of cultural connection and leaving a lasting positive impression.

Building Bridges and Collaborations: Networking at its Finest

PiVOT’s General Manager Ella Mae Ortega with DIA President Marwan Fathallah

Beyond showcasing Philippine capabilities, PiVOT actively engaged with industry leaders at the event. General Manager, Ms. Ella Mae Ortega, had the privilege of meeting key figures like DIA President Marwan Fathallah during the ACRO Networking event. This high-level interaction strengthens PiVOT’s position within the global clinical research landscape.

She also connected with Nimita Limiye, a distinguished figure in the life sciences industry. Ms. Limiye, the recipient of the DIA Global Connector Award at the Inspire Awards Ceremony, is renowned for her work in promoting global collaborations and advancing DIA’s mission. Her experience in diverse initiatives like real-world data utilization and decentralized clinical trials makes her a valuable asset to the industry.

Ella Mae Ortega with DIA 2024 Inspire Awardee Ms. Nimita Limaye

Another notable DIA 2024 Inspire Award winner, Aaron Horowitz, co-founder and CEO of Empath Labs (formerly Sproutel), also visited the PiVOT booth. Empath Labs focuses on developing innovative products that bring comfort and joy to patients, exemplified by their creation of Jerry the Bear, a companion for children with type 1 diabetes. Such connections solidify PiVOT’s commitment to innovation and patient-centricity within the clinical research space.

Furthermore, the PiVOT team fostered valuable interactions with fellow Asian companies such as A2 Healthcare, EPS, LSK, and CMIC. These connections lay the groundwork for future partnerships that can accelerate clinical research advancements across the region.

PiVOT with A2 Healthcare

PiVOT with CMIC

PiVOT team with EPS Group

PiVOT team with Clinical Research Malaysia

A Familiar Face: Filipinos Making Global Connections

An unexpected delight for PiVOT was the high number of booth visitors with Filipino connections. This familiarity fostered a warm and welcoming atmosphere, further highlighting the positive perception of Filipino expertise and hospitality. These interactions demonstrate the growing global presence of Filipinos within the life sciences industry. PiVOT, by showcasing Philippine capabilities, not only promotes clinical research opportunities in the country but also celebrates the Filipino talent driving innovation on a global scale.

With Dr. Editha Mabazza of HCLTech

With Alex Bragat, A proud Filipino who is the head of Data Management of N Power Medicine

Paving the Way for PINNACLE: Sharing the Knowledge Gained

The knowledge and experience gained at DIA 2024 will be invaluable for PiVOT’s yearly event – PINNACLE, the Philippines’ premier clinical research gathering. This one-night event brings together key stakeholders in the Philippine clinical research space for an evening of learning and collaboration.

PiVOT’s insights obtained from DIA will be central to shaping PINNACLE, ensuring it serves as a platform for knowledge-sharing, fostering collaboration, and driving the Philippines’ rise as a clinical research powerhouse.

The Philippines: A Rising Star in Clinical Research

PiVOT’s successful participation at DIA 2024 underscores the Philippines’ potential as a global destination for clinical research. With its talent pool, patient diversity, and cost-effectiveness, the Philippines is poised to play a significant role in accelerating medical advancements worldwide.

PiVOT Delegates (L-R) Christian Vizcarra, Ella Mae Ortega, Cheng Bigay, and Risa Takatsu

By showcasing its capabilities and fostering connections with industry leaders, PiVOT is paving the way for a brighter future of clinical research in the Philippines. As the momentum builds, the Philippines’ role in shaping the future of healthcare globally is assured.